Mallinckrodt's INOmax approved In Australia and Japan for pulmonary hypertension in conjunction with heart surgery

30 October 2015 - The indication in Australia has been expanded to include use of INOmax for peri- and post-operative pulmonary hypertension in conjunction with cardiovascular surgery in infants and children up to age 17.

For more details, go to: http://www.mallinckrodt.com/about/news-and-media/2104609

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Outcome , Medicine , Australia